UNSPSC 51182069: Testosterone cypionate

This classification denotes a therapeutic testosterone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M0XW1UBI14. European Medicines Agency schedules Testosterone cipionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04734MIG. Testosterone cypionate generally arises in the molecular formula C27H40O3. The term 'testosterone cypionate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule testosterone cypionate under HS 29372900.

As of Q4 2014, TESTOSTERONE CYPIONATE remains US FDA's Preferred Term for this commodity. Testosterone cypionate bears US NLM identifiers UMLS ID C0076181 and NCI Concept Code C1246. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=CC(=O)CC[C@]35C.

UNSPSC 51182069 Testosterone cypionate is a Commodity code for a specific pharmaceutical product that state and local governments procure through cooperative purchasing agreements to stock in institutional facilities including correctional systems, public health clinics, and state hospital networks. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, actively solicits manufacturers and authorized distributors of generic pharmaceuticals and over-the-counter products under this code as part of broad multi-source procurement vehicles that consolidate demand across participating states and local jurisdictions. State agencies and local government health systems are the primary buyers, purchasing through cooperative contracts that establish pricing tiers and supply chain routing via three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—rather than direct institutional procurement. Vendors must hold current Good Manufacturing Practices certification, comply with the Drug Supply Chain Security Act, maintain contractual relationships with at least two of the three authorized wholesalers, carry comprehensive insurance including $5 million in commercial general liability coverage, and meet performance penalties ranging from $200 to $1,500 per violation for reporting delays or supply failures.

MMCAP's Request for Proposal S1070000015802, posted January 20, 2026, with a March 26, 2026 response deadline, represents the most recent solicitation activity under this code. The RFP establishes multiple contracts with a two-year term for new vendors and optional extensions, with awarded vendors taking effect July 1, 2026, contingent on product availability by May 15, 2026. Pricing evaluation weighted heavily toward price competitiveness (75 percent) with secondary consideration of fixed pricing format, EDI capability, administrative fee compliance, and data format adherence. The source does not identify specific geographic concentration beyond Minnesota and Oregon participation in the MMCAP cooperative vehicle, nor does it disclose award values, budget ranges, or set-aside designations limiting responses to disadvantaged business enterprises.